Cargando…
Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding
[Image: see text] One of the leading sources of false positives in early drug discovery is the formation of organic small molecule aggregates, which inhibit enzymes nonspecifically at micromolar concentrations in aqueous solution. The molecular basis for this widespread problem remains hazy. To inve...
Autores principales: | Coan, Kristin E. D., Maltby, David A., Burlingame, Alma L., Shoichet, Brian K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2009
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664636/ https://www.ncbi.nlm.nih.gov/pubmed/19281222 http://dx.doi.org/10.1021/jm801605r |
Ejemplares similares
-
Embracing enzyme promiscuity with activity-based compressed biosensing
por: Holt, Brandon Alexander, et al.
Publicado: (2022) -
Data structures for compound promiscuity analysis: promiscuity cliffs, pathways and promiscuity hubs formed by inhibitors of the human kinome
por: Miljković, Filip, et al.
Publicado: (2019) -
A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors
por: Mateen, Rabia, et al.
Publicado: (2018) -
Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based
MDMX Inhibitors
por: Stefaniak, Jakub, et al.
Publicado: (2018) -
Colloidal Aggregation
Affects the Efficacy of Anticancer
Drugs in Cell Culture
por: Owen, Shawn C., et al.
Publicado: (2012)